Mario E. Lacouture

Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib

M. Lacouture, G. Dranitsaris, M. Vincent, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group

Lynne Wagner, Dennis P. West, Ethan Basch, 2010, Supportive Care in Cancer.

Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine

M. Lacouture, G. Dranitsaris, George Dranitsaris, 2014, Breast Cancer Research and Treatment.